INHALE-AIDEx inhaled insulin around post-meal exercise
What this study tests
Randomized crossover study asking whether inhaled Technosphere insulin for a meal is safer than a pump-delivered rapid-acting analogue when adults using Control-IQ exercise soon after eating.
Editorial review: .
Registry checked: 2026-09-17. Registry’s own update: 2026-07-16.
Most recent recorded citation date: 2025-03-18. Only explicit date metadata is included; an undated citation may be newer. This does not mean every claim was reviewed on that date.
Trial status, labels and access can change between reviews. How we review the evidence · How to read the evidence
Evidence at a glance
- Who can enter the study?
- Adults aged 18-65 with T1D using Tandem t:slim X2 or Mobi with Control-IQ or Control-IQ+; see registry for full criteria. Registered eligibility ↗Enrollment criteria describe who may enter. They do not establish who was analyzed or the denominator for a reported result.
- Reported benefit and results
- No results posted. The study is recruiting an estimated 30 participants and expects primary completion in October 2026.Read the result sources and their limitations →
- Important harms
- Read the reported results, safety discussion and original sources. A separate harms summary is not available; this does not establish safety.
- Research access and approval
- Study regions: United States. A trial listing does not establish product approval or current recruitment at a particular site. Check the study’s current entry requirements.
- What remains uncertain?
- Read the full discussion and original sources for study limitations. Planned endpoints and completion dates are not results.
Research status alone does not establish approval, clinical benefit or local availability.
Primary endpoints
- Blood glucose below 70 mg/dL during the 90-minute exercise period
The full picture
This record has no longer discussion. Use the study criteria, reported results and original sources on this page to assess what is known and what remains unresolved.
Sources
- [1]NCT06880835: INHALE-AIDEx — inhaled versus pump-delivered insulin around exercise · Trial registry · 2025-03-18 — RECRUITING; estimated n=30; United States; primary completion October 2026; registry update posted 2026-07-16.